153 related articles for article (PubMed ID: 28718199)
1. The CLEC12A receptor marks human basophils: Potential implications for minimal residual disease detection in acute myeloid leukemia.
Toft-Petersen M; Stidsholt Roug A; Plesner T; Ebbesen L; Brown GD; Nederby L
Cytometry B Clin Cytom; 2018 May; 94(3):520-526. PubMed ID: 28718199
[TBL] [Abstract][Full Text] [Related]
2. hMICL and CD123 in combination with a CD45/CD34/CD117 backbone - a universal marker combination for the detection of minimal residual disease in acute myeloid leukaemia.
Roug AS; Larsen HØ; Nederby L; Just T; Brown G; Nyvold CG; Ommen HB; Hokland P
Br J Haematol; 2014 Jan; 164(2):212-22. PubMed ID: 24152218
[TBL] [Abstract][Full Text] [Related]
3. Expression of the hMICL in acute myeloid leukemia-a highly reliable disease marker at diagnosis and during follow-up.
Larsen HØ; Roug AS; Just T; Brown GD; Hokland P
Cytometry B Clin Cytom; 2012 Jan; 82(1):3-8. PubMed ID: 22173921
[TBL] [Abstract][Full Text] [Related]
4. Unravelling the relevance of CLEC12A as a cancer stem cell marker in myelodysplastic syndrome.
Toft-Petersen M; Nederby L; Kjeldsen E; Kerndrup GB; Brown GD; Hokland P; Stidsholt Roug A
Br J Haematol; 2016 Nov; 175(3):393-401. PubMed ID: 27612176
[TBL] [Abstract][Full Text] [Related]
5. Revisiting CLEC12A as leukaemic stem cell marker in AML: highlighting the necessity of precision diagnostics in patients eligible for targeted therapy.
Bill M; Aggerholm A; Kjeldsen E; Roug AS; Hokland P; Nederby L
Br J Haematol; 2019 Mar; 184(5):769-781. PubMed ID: 30520015
[TBL] [Abstract][Full Text] [Related]
6. Prognostic and therapeutic role of CLEC12A in acute myeloid leukemia.
Morsink LM; Walter RB; Ossenkoppele GJ
Blood Rev; 2019 Mar; 34():26-33. PubMed ID: 30401586
[TBL] [Abstract][Full Text] [Related]
7. CLEC12A plays an important role in immunomodulatory function and prognostic significance of patients with acute myeloid leukemia.
Li Q; Liang C; Xu X; Zhang C; Cao W; Wang M; Jiang Z; Xing H; Yu J
Leuk Lymphoma; 2022 Sep; 63(9):2136-2148. PubMed ID: 35481814
[TBL] [Abstract][Full Text] [Related]
8. Antigen Expression Varies Significantly between Molecular Subgroups of Acute Myeloid Leukemia Patients: Clinical Applicability Is Hampered by Establishment of Relevant Cutoffs.
Herborg LL; Nederby L; Brøndum RF; Hansen M; Hokland P; Roug AS
Acta Haematol; 2021; 144(3):275-284. PubMed ID: 33271547
[TBL] [Abstract][Full Text] [Related]
9. Mapping the CLEC12A expression on myeloid progenitors in normal bone marrow; implications for understanding CLEC12A-related cancer stem cell biology.
Bill M; B van Kooten Niekerk P; S Woll P; Laine Herborg L; Stidsholt Roug A; Hokland P; Nederby L
J Cell Mol Med; 2018 Apr; 22(4):2311-2318. PubMed ID: 29411522
[TBL] [Abstract][Full Text] [Related]
10. ENPP4 and HOXA3 as potential leukaemia stem cell markers in acute myeloid leukaemia.
Mohd Amin A; Panneerselvan N; Md Noor S; Mohtaruddin N; Sathar J; Norbaya WS; Osman R; Kee LH; Mohd Yaakub WH; Cheong SK; Abdullah M
Malays J Pathol; 2023 Apr; 45(1):65-76. PubMed ID: 37119247
[TBL] [Abstract][Full Text] [Related]
11. The Fusion of
Dhungel BP; Monteuuis G; Giardina C; Tabar MS; Feng Y; Metierre C; Ho S; Nagarajah R; Fontaine ARM; Shah JS; Gokal D; Bailey CG; Schmitz U; Rasko JEJ
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830054
[TBL] [Abstract][Full Text] [Related]
12. Expression of the myeloid inhibitory receptor CLEC12A correlates with disease activity and cytokines in early rheumatoid arthritis.
Vaillancourt M; Desaulniers P; Paré G; Pagé N; Lachhab A; Kerever A; Julien AS; Amiable N; Pelletier M; Tessier PA; Bessette L; Michou L; Fortin PR; Fernandes MJ
Sci Rep; 2021 May; 11(1):11248. PubMed ID: 34045571
[TBL] [Abstract][Full Text] [Related]
13. The uric acid crystal receptor Clec12A potentiates type I interferon responses.
Li K; Neumann K; Duhan V; Namineni S; Hansen AL; Wartewig T; Kurgyis Z; Holm CK; Heikenwalder M; Lang KS; Ruland J
Proc Natl Acad Sci U S A; 2019 Sep; 116(37):18544-18549. PubMed ID: 31451663
[TBL] [Abstract][Full Text] [Related]
14. NRP-1/CD304 expression in acute leukemia: a potential marker for minimal residual disease detection in precursor B-cell acute lymphoblastic leukemia.
Meyerson HJ; Blidaru G; Edinger A; Osei E; Schweitzer K; Fu P; Ho L
Am J Clin Pathol; 2012 Jan; 137(1):39-50. PubMed ID: 22180477
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the Expression, Oligomerisation and Signaling of the Inhibitory Receptor CLEC12A by Cysteine Residues in the Stalk Region.
Vitry J; Paré G; Murru A; Charest-Morin X; Maaroufi H; McLeish KR; Naccache PH; Fernandes MJ
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638548
[TBL] [Abstract][Full Text] [Related]
16. Human myeloid inhibitory C-lectin: a highly specific and stable acute myeloid leukemia marker.
Eissa DS; Kandeel EZ; Ghareeb M
Hematol Oncol; 2017 Dec; 35(4):814-820. PubMed ID: 27734526
[TBL] [Abstract][Full Text] [Related]
17. A trispecific killer engager molecule against CLEC12A effectively induces NK-cell mediated killing of AML cells.
Arvindam US; van Hauten PMM; Schirm D; Schaap N; Hobo W; Blazar BR; Vallera DA; Dolstra H; Felices M; Miller JS
Leukemia; 2021 Jun; 35(6):1586-1596. PubMed ID: 33097838
[TBL] [Abstract][Full Text] [Related]
18. The Inhibitory Receptor CLEC12A Regulates PI3K-Akt Signaling to Inhibit Neutrophil Activation and Cytokine Release.
Paré G; Vitry J; Merchant ML; Vaillancourt M; Murru A; Shen Y; Elowe S; Lahoud MH; Naccache PH; McLeish KR; Fernandes MJ
Front Immunol; 2021; 12():650808. PubMed ID: 34234773
[TBL] [Abstract][Full Text] [Related]
19. Antibody-mediated targeting of antigen to C-type lectin-like receptors Clec9A and Clec12A elicits different vaccination outcomes.
Macri C; Dumont C; Panozza S; Lahoud MH; Caminschi I; Villadangos JA; Johnston AP; Mintern JD
Mol Immunol; 2017 Jan; 81():143-150. PubMed ID: 27978488
[TBL] [Abstract][Full Text] [Related]
20. Antibody blockade of CLEC12A delays EAE onset and attenuates disease severity by impairing myeloid cell CNS infiltration and restoring positive immunity.
Sagar D; Singh NP; Ginwala R; Huang X; Philip R; Nagarkatti M; Nagarkatti P; Neumann K; Ruland J; Andrews AM; Ramirez SH; Khan ZK; Jain P
Sci Rep; 2017 Jun; 7(1):2707. PubMed ID: 28578388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
